These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

75 related items for PubMed ID: 2772076

  • 1. [Initial experiences with the Reiber 1979 determination of autochthonous IgG production within the scope of clinical and immunologic follow-up studies in multiple sclerosis treated with immunosuppressive therapy].
    Dachsel R, Köppel C.
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jul; 41(7):420-5. PubMed ID: 2772076
    [Abstract] [Full Text] [Related]

  • 2. [Immunosuppressive treatment of multiple sclerosis (review of the literature].
    Neretin VIa, Kir'iakov VA, Sapfirova VA.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990 Jul; 90(2):119-26. PubMed ID: 2160156
    [No Abstract] [Full Text] [Related]

  • 3. High-dose cyclophosphamide for moderate to severe refractory multiple sclerosis.
    Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK.
    Arch Neurol; 2006 Oct; 63(10):1388-93. PubMed ID: 16908728
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Isoprinosine in multiple sclerosis treatment: a preliminary study.
    Mazzarello P, Rocchelli B, Poloni M, Delodovici M, Pinelli P.
    Schweiz Arch Neurol Neurochir Psychiatr; 1982 Oct; 131(2):175-9. PubMed ID: 6187064
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of treatment with Encorton (Polfa), Solu-Medrol and Encorton and Cyclophosphamide and Encorton on the production of immunoglobulin G in the central nervous system in multiple sclerosis].
    Ochudło S.
    Wiad Lek; 1989 Dec 01; 41(23):1579-83. PubMed ID: 2669352
    [No Abstract] [Full Text] [Related]

  • 8. [Intensive immunosuppressive treatment of chronic progressive multiple sclerosis].
    Hommes OR.
    Ned Tijdschr Geneeskd; 1978 Oct 14; 122(41):1545-51. PubMed ID: 358004
    [No Abstract] [Full Text] [Related]

  • 9. Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis.
    Valsakumar AK, Valappil UC, Jorapur V, Garg N, Nityanand S, Sinha N.
    J Rheumatol; 2003 Aug 14; 30(8):1793-8. PubMed ID: 12913937
    [Abstract] [Full Text] [Related]

  • 10. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW, Fluck RJ, Lambie SH.
    Clin Nephrol; 2001 Sep 14; 56(3):193-8. PubMed ID: 11597033
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Immunosuppressive medication in multiple sclerosis].
    García Merino JA.
    Rev Neurol; 2001 Sep 14; 35(12):1154-8. PubMed ID: 12497298
    [Abstract] [Full Text] [Related]

  • 13. [Treatment of progressive and severe forms of multiple sclerosis using a combination of antilymphocyte serum, azathioprine and prednisone. Clinical and biological results. Comparison with a control group treated with azathioprine and prednisone only. 4-year follow-up].
    Lhermitte F, Marteau R, de Saxcé H.
    Rev Neurol (Paris); 1987 Sep 14; 143(2):98-107. PubMed ID: 3299618
    [Abstract] [Full Text] [Related]

  • 14. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
    Petrović R, Stojanović R, Novicić-Sasić D, Dimitrijević J, Pavlović S, Stojković D, Palić-Obradović D, Stevanović G, Prodanović S.
    Srp Arh Celok Lek; 2002 Aug 14; 130 Suppl 3():19-25. PubMed ID: 12583309
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serial combination therapy: is immune modulation in multiple sclerosis enhanced by initial immune suppression?
    Bar-Or A, Oger J, Gibbs E, Niino M, Aziz T, Renoux C, Alatab S, Shi FD, Campagnolo D, Jalili F, Rhodes S, Yamashita T, Fan B, Freedman MS, Panitch H, Arnold DL, Vollmer T.
    Mult Scler; 2009 Aug 14; 15(8):959-64. PubMed ID: 19667022
    [Abstract] [Full Text] [Related]

  • 17. Randomized study of interferon beta-1a, low-dose azathioprine, and low-dose corticosteroids in multiple sclerosis.
    Havrdova E, Zivadinov R, Krasensky J, Dwyer MG, Novakova I, Dolezal O, Ticha V, Dusek L, Houzvickova E, Cox JL, Bergsland N, Hussein S, Svobodnik A, Seidl Z, Vaneckova M, Horakova D.
    Mult Scler; 2009 Aug 14; 15(8):965-76. PubMed ID: 19465443
    [Abstract] [Full Text] [Related]

  • 18. [How long should cyclophosphamide therapy of Wegener's granulomatosis continue?].
    Reinhold-Keller E.
    Dtsch Med Wochenschr; 2002 Sep 13; 127(37):1909-10. PubMed ID: 12226791
    [No Abstract] [Full Text] [Related]

  • 19. The clinical value of commonly used spinal fluid diagnostic studies in the evaluation of patients with suspected multiple sclerosis.
    Brasher GW, Follender AB, Spiekerman AM.
    Am J Manag Care; 1998 Aug 13; 4(8):1119-21. PubMed ID: 10182887
    [Abstract] [Full Text] [Related]

  • 20. [Aspects of immunosuppressive therapy of multiple sclerosis].
    Fischer W.
    Psychiatr Neurol Med Psychol Beih; 1975 Aug 13; 20-21():23-6. PubMed ID: 829627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.